U.S. patent number D323,709 [Application Number 07/171,523] was granted by the patent office on 1992-02-04 for combined guard and injection site for intravenous infusion or the like. This patent grant is currently assigned to Migada, Inc.. Invention is credited to Michael R. Pescovitz, Philip Wyatt.
United States Patent | D323,709 |
Wyatt , et al. | * February 4, 1992 |
Inventors: | Wyatt; Philip (Glendale, CA), Pescovitz; Michael R. (Saugus, CA) |
---|---|
Assignee: | Migada, Inc. (Burbank,
CA) |
[*] Notice: | The portion of the term of this patent subsequent to February 11, 2006 has been disclaimed. |
Appl. No.: | 07/171,523 |
Filed: | March 21, 1988 |
Current U.S. Class: | D24/129 |
Field of Search: | ;D24/53,51 ;604/87,86 ;285/93 ;138/103,140 |
3898988 | August 1975 | Morgan |
3990445 | November 1976 | Lundquist |
4048995 | September 1977 | Mittleman |
4133441 | January 1979 | Mittleman et al. |
4781680 | November 1988 | Redmond et al. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.